ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1

ELI LILLY AND COMPANY CEDEAR EACH 56 REP 1

No trades
See on Supercharts

Key facts today

Eli Lilly's Lyumjev ultra-rapid insulin is now approved for use with Tandem Diabetes Care's t:slim X2 pump in the EU, with plans to expand compatibility to other regions and the Tandem Mobi pump.
Analyze the impactAnalyze the impact
Market capitalization
‪827.82 T‬ARS
106.804ARS
‪1.54 T‬ARS
‪10.05 T‬ARS
Beta (1Y)
0.36

About Eli Lilly and Company


CEO
David A. Ricks
Headquarters
Indianapolis
Website
Employees (FY)
‪43 K‬
Founded
1876
ISIN
ARDEUT111192
FIGI
BBG000HFTQS8
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy